Glucagon-receptor Signaling Regulates Energy Metabolism Via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21
Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 12, 2017
- Accepted June 11, 2018
- Published online ahead of print June 20, 2018.
Article Versions
- You are currently viewing a Previous version of this article (June 20, 2018 - 06:39).
- View the most recent version of this article
Copyright & Usage
© 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Author Information
- Teayoun Kim1,
- Shelly Nason1,
- Cassie Holleman1,
- Mark Pepin2,
- Landon Wilson5,
- Taylor F Berryhill5,
- Adam R. Wende2,
- Chad Steele3,
- Martin E. Young4,
- Stephen Barnes5,
- Daniel J. Drucker6,
- Brian Finan7,
- Richard DiMarchi7,8,
- Diego Perez-Tilve9,
- Matthias Tschoep10 and
- Kirk M Habegger1,#
- 1Comprehensive Diabetes Center and Department of Medicine - Endocrinology, Diabetes & and Metabolism, University of Alabama at Birmingham, Birmingham, AL USA
- 2Department of Pathology – Molecular & Cellular Pathology, University of Alabama at Birmingham, AL, USA
- 3Department of Medicine-Pulmonary/Allergy/Critical Care, University of Alabama at Birmingham, Birmingham, AL, USA
- 4Department of Medicine-Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA
- 5Department of Pharmacology, University of Alabama at Birmingham, Birmingham, AL, USA
- 6Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Department of Medicine, University of Toronto, Toronto, ON, CA
- 7Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA
- 8Dept. of Chemistry, Indiana University, Bloomington, IN, USA
- 9Metabolic Disease Institute, Div. of Endocrinology, Diabetes and Metabolism, University of Cincinnati, Cincinnati OH, USA
- 10Institute for Diabetes and Obesity, Helmholtz Zentrum München, München, Germany
- #Corresponding author: Kirk M Habegger, E-mail: kirkhabegger{at}uabmc.edu